Titoli del Settore Sanitario
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1848 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 13.95 USD | -1.34% | -2.52% | +1.23% | +102.17% | 1.98 B USD | ||
| 1851 |  BHC Bausch Health Companies Inc. Common Stock | 5.32 USD | -0.93% | -3.80% | -6.01% | +17.18% | 1.99 B USD | ||
| 1852 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 15.31 USD | -0.13% | +0.39% | +1.12% | +28.33% | 1.97 B USD | ||
| 1853 |  ABCL AbCellera Biologics Inc. - Common Shares | 6.45 USD | +4.37% | +21.70% | +45.27% | +219.31% | 1.97 B USD | ||
| 1855 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.79 USD | +5.57% | +25.08% | +11.47% | -9.33% | 2.01 B USD | ||
| 1856 |  NTLA Intellia Therapeutics, Inc. - Common Stock | 0.14 USD | -2.42% | -98.90% | -98.95% | -98.98% | 19.18 M USD | ||
| 1858 |  OCUL Ocular Therapeutix, Inc. - Common Stock | 8.93 USD | +9811.21% | +8.51% | -4.70% | -22.35% | 1.96 B USD | ||
| 1861 |  CMPS COMPASS Pathways Plc - American Depository Shares | 14.19 USD | +8.65% | +16.41% | +54.58% | +122.76% | 1.91 B USD | ||
| 1864 |  NEOG Neogen Corporation - Common Stock | 8.92 USD | -0.56% | +0.45% | -5.51% | +51.70% | 1.94 B USD | ||
| 1871 |  NVCR NovoCure Limited - Ordinary Shares | 16.56 USD | +9618.31% | -8.00% | +0.79% | +20.44% | 1.92 B USD | ||
| 1874 |  PHVS Pharvaris N.V. - Ordinary Shares | 29.10 USD | -3.51% | -3.19% | +0.24% | +75.30% | 1.90 B USD | ||
| 1876 |  SRPT Sarepta Therapeutics, Inc. - Common Stock | 17.61 USD | -1.45% | +4.26% | -16.86% | -53.63% | 1.86 B USD | ||
| 1879 |  MESO Mesoblast Limited - American Depositary Shares | 14.86 USD | -3.51% | -1.65% | -5.41% | +41.52% | 1.90 B USD | ||
| 1883 |  STOK Stoke Therapeutics, Inc. - Common Stock | 30.47 USD | -1.42% | +3.29% | -7.22% | +215.75% | 1.90 B USD | ||
| 1890 |  SION Sionna Therapeutics, Inc. - Common Stock | 40.90 USD | +9451.61% | -4.53% | +5.85% | +3.97% | 1.85 B USD | ||
| 1898 |  NBTX Nanobiotix S.A. - ADSs | 38.00 USD | -5.94% | -11.11% | +19.65% | +804.76% | 1.84 B USD | ||
| 1899 |  HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 31.81 USD | +9969.64% | +5.51% | +0.35% | +2.94% | 1.84 B USD | ||
| 1901 |  TYRA Tyra Biosciences, Inc. - Common Stock | 0.30 USD | -9.04% | -99.08% | -99.12% | -97.91% | 18.07 M USD | ||
| 1905 |  ADMA ADMA Biologics Inc - Common Stock | 7.89 USD | -1.13% | -4.01% | -24.50% | -60.25% | 1.83 B USD | ||
| 1910 |  ATAI AtaiBeckley Inc. - Common Stock | 0.05 USD | -98.94% | -98.84% | -98.79% | -98.73% | 17.75 M USD |
Notizie Titoli del Settore Sanitario
Teleflex prezza un’offerta di obbligazioni senior da $500 milioni al 5,875%
Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Care Transcript
Perché il titolo Fulcrum Therapeutics crolla nel dopo-borsa?
Abivax inverte la rotta: titolo giù del 40% nonostante dati positivi
Wolfe Research avvia copertura su Repligen con rating outperform
Wolfe Research avvia la copertura di Waters con rating Outperform
Wolfe Research avvia copertura su Stevanato con rating Outperform
Gainers Titoli del Settore Sanitario
 EWTX Edgewise Therapeutics, Inc. - Common Stock | 40.26 | +11685.71% |
 MBIO Mustang Bio, Inc. - Common Stock | 0.77 | +11392.54% |
 PMI Picard Medical, Inc. Common Stock | 0.17 | +11233.33% |
 HYPD Hyperion DeFi, Inc. - Common Stock | 3.86 | +10928.57% |
 CLYM Climb Bio, Inc. - Common Stock | 11.80 | +10666.42% |
 ADGM Adagio Medical Holdings, Inc - Common Stock | 0.77 | +10594.44% |
 ORIC Oric Pharmaceuticals, Inc. - Common Stock | 8.98 | +10527.22% |
 PIII P3 Health Partners Inc. - Class A Common Stock | 12.91 | +10499.34% |
